Infertility means a couple has not achieved a clinical pregnancy after at least 12 months of regular, unprotected intercourse. Sterility is the stronger word: it means no live birth is biologically possible for that person using their own gametes and uterus — as with azoospermia or the congenital absence of a uterus.
Most people searching these two terms fall into the first category, not the second.
The ProIVF Medical Editorial Team compiled this article from the ICMART/WHO international glossary, a WHO-cited global prevalence meta-analysis and peer-reviewed male-infertility studies, then had it reviewed by the ProIVF Medical Advisory Board.
What is the actual difference between infertility and sterility?
Infertility is a failure to establish a pregnancy; sterility is an inability that cannot be overcome by treating that person’s own body. A couple with severe ovulation problems may be infertile for years yet fully capable of carrying a child once medication restores ovulation.
A man with untreated non-obstructive azoospermia who responds to no therapy is sterile — his testes produce no sperm at all, so no treatment of his own body will ever yield one.
The definitions above follow the International Glossary on Infertility and Fertility Care published jointly by ICMART and the World Health Organization (Fertil Steril 2017), which was updated again in 2025. The glossary lists classic examples of sterility: azoospermia, absence of testes, absence of ovaries and absence of a uterus. Everything short of those absolute states counts as infertility — a treatable disease, not a verdict.
A third word sits between them: subfertility, meaning reduced fertility that still permits spontaneous pregnancy, often just with more time. Clinics keep it in the vocabulary precisely because labeling a couple who can still conceive — just more slowly — as “sterile” would be wrong, and would push them toward treatment they may never have needed.
How common is infertility worldwide?
About 1 in 6 people experience infertility at some point in their lives, according to the meta-analysis that WHO uses as its official estimate.
“Pooled estimates of lifetime and period prevalence were 17.5% (95% CI: 15.0, 20.3, n = 37 studies, I² = 99.5%) and 12.6% (95% CI: 10.7, 14.6, n = 43 studies, I² = 99.8%), respectively.” — Cox et al., Human Reproduction Open, 2022 (PMID 36483694)
That study pooled 65 population studies for lifetime prevalence and 69 for 12-month period prevalence, and found individual-country lifetime estimates ranging from 3.3% to 39.7% — infertility is genuinely global, but its measured burden swings with how each country counts. Two related figures frame the trend: the age-standardized prevalence of male infertility stood at roughly 1,403 per 100,000 men in 2019, up about 19% since 1990 (GBD analysis, BMC Public Health 2023), and in India’s first pooled estimate, infertility affected 8% of women overall — 5% primary and 2% secondary (Reprod Health 2026).
True sterility is far rarer. Complete absence of sperm in the ejaculate — azoospermia — affects about 1% of all men, and roughly 10–15% of men evaluated for infertility (PMID 39268812).
Is primary infertility different from secondary infertility?
Yes — and the distinction matters clinically and emotionally. Primary infertility applies when neither partner has ever achieved a pregnancy; secondary infertility applies when at least one previous pregnancy occurred, even if it ended in miscarriage or a live birth.
Secondary infertility is common: in the Indian pooled estimate above, 2% of all women had secondary infertility — about two-fifths of the total infertility burden. The causes skew differently too. Secondary cases are more often tubal damage from prior surgery or infection, uterine problems such as cesarean-scar defects, and simple age gap between children, while primary cases more often involve ovulation disorders, endometriosis or lifelong male factors. See our guides to female infertility causes and male infertility and IVF for the full breakdown.
What are the real causes of sterility?
Only a handful of conditions meet the strict definition — all of them rare, and each with a known work-around:
Absent or non-functioning sperm production. Non-obstructive azoospermia (NOA) accounts for about 60% of azoospermia cases; the remaining 20–40% are obstructive (sperm made but blocked from exiting).
Absent or non-functioning egg supply. Natural menopause ends egg availability; surgical removal of both ovaries or premature ovarian insufficiency does so earlier. A uterus that cannot carry — absent congenitally (MRKH syndrome), removed, or unresponsive after radiation — completes the classic sterility set the WHO glossary describes.
No available partner gametes or legal path. In some jurisdictions, third-party options (donor eggs, surrogacy) are themselves unlawful, converting a biologically solvable problem into a practical dead end. That legal layer is covered country-by-country in our guide to IVF laws by country.
The important clinical point: most “sterility” diagnoses are actually severe infertility — a distance problem, not an absolute wall.
Can sterile people still become parents?
Yes, in most cases — through a different biological route than the one they assumed. Here is what the evidence supports, diagnosis by diagnosis.
| Situation | What medicine can still do | Key number |
|---|---|---|
| Azoospermia (obstructive) | Sperm retrieved from epididymis/testes + ICSI | MESA-ICSI live-birth 39% vs TESE 24% per cycle (PMID 25740877) |
| Non-obstructive azoospermia | Surgical sperm retrieval with IVF/ICSI | Sperm found in 47% of NOA retrieval operations (PMID 31665451) |
| No eggs / menopause / very low reserve | Donor-egg IVF using a younger woman’s eggs | Donor-egg success rates plateau near 50–60% per transfer regardless of recipient age — see donor egg IVF |
| No functional uterus | Gestational carrier (where lawful) | Legal in 15 of 43 surveyed European countries (Hum Reprod 2024) |
| Hormonal shut-down (hypogonadotropic hypogonadism) | Gonadotropin therapy restores sperm production | Sperm production induced in 82% of men with prepubertal-onset pituitary causes (PMID 40878119) |
Two cautions the data deserves. First, that 47% NOA retrieval figure means more than half of micro-TESE operations find no sperm — men with NOA should be counseled about that before surgery, and repeated retrievals succeed less often (28.8% vs 64.6% the first time, PMID 40446124). Second, having a genetic-link workaround differs from having a legal one: in several countries the medically possible path is the unlawful one.
And no technology defeats age. The landmark cumulative-success analysis concluded it in one sentence: IVF “may largely overcome infertility in younger women, but it does not reverse the age-dependent decline in fertility” (N Engl J Med 2009) — after six cycles, cumulative live-birth rates reached 86% under 35 versus 42% at 40+ (optimistic assumption). That is why “sterile” and “older” are not the same problem, and why we treat them separately in success rates by age.
When should you stop waiting and get tested?
Get evaluated after 12 months of unprotected, regular intercourse if you are under 35, and after 6 months if you are 35 or older — the timing recommended by ASRM and ACOG. Do not wait out any of those windows if a known sterility or infertility risk already exists: a prior azoospermia result, chemotherapy or pelvic radiation, confirmed blockage of both fallopian tubes, recurrent miscarriages, or a testicular condition.
A full checklist of warning signs is in signs of infertility.
The waiting period exists because most couples conceive inside it: standard ASRM/ACOG teaching puts natural conception within the first year at roughly 85% of couples. The 12-month rule is a triage line, not a permission slip.
Three stories: infertile, subfertile, and called sterile
The accounts below are illustrative composites drawn from common clinical scenarios; names, faces and identifying details have been changed, and no real patient or couple is depicted.
Kris, 34, with wife Ann, 32 — obstructive azoospermia, Bangkok. A semen analysis showed zero sperm; hormones and testicular size were normal, pointing to blockage rather than failure. They traveled to a Thai clinic where the team retrieved sperm directly from the epididymis and injected one into each mature egg (ICSI). Total cycle cost ≈ US$9,500. Two blastocysts resulted; the first transfer took, and they had a son the following year. “We were told ‘no sperm’ and heard ‘never’,” Ann says. “What it actually meant was ‘not from the ejaculate.’ There was a whole plan B sitting behind those three words.”
Mei, 36, second child — secondary infertility, Kuala Lumpur. One vaginal birth, then a cesarean for her second pregnancy that never came. Six years of trying after the surgery; testing found the cesarean scar had thinned her lining. Three medicated frozen-transfer cycles at a Malaysian clinic (≈ US$3,200 per transfer) ended in her second child. “The first birth was easy and the second took six years. Nobody warns you that having succeeded once is not the same as still being able to.”
Sofia, 39, partner Lena, 41 — called sterile, went with donor eggs, Barcelona. Two rounds of IVF with Sofia’s own eggs yielded one embryo each time; her AMH was near zero. The couple moved to Spain for donor-egg treatment (≈ €7,400 including medication and travel), a clinic matching the donor’s profile, and legal parentage for both mothers on the birth certificate. “The doctor said ‘your ovaries are done’ — that is sterility, clinically. But what I got was a baby who nurses at my chest. Biology handed me one door; the law and the clinic opened another.”
FAQ
Q: Does being diagnosed with infertility mean I am sterile?
No. Infertility is measured in time — no clinical pregnancy after 12 months of trying — while sterility requires that a live birth be biologically impossible without donation or a carrier.
About 85% of couples conceive within 12 months and roughly 92% within 24 months without advanced help; the small remainder is where true sterility lies, and it is a minority even among infertility patients.
Q: How many months of trying is officially infertility?
12 months under age 35; 6 months at 35 or older; immediately at any age with a known risk such as azoospermia, prior chemotherapy or recurrent pregnancy loss. These are ASRM/ACOG evaluation thresholds, not rules about when hope ends.
Q: Can a man with zero sperm ever have a biological child?
Often, yes. In obstructive azoospermia sperm production is intact, and retrieval with ICSI achieves live birth in up to 39% of transfer cycles (PMID 25740877).
In non-obstructive azoospermia, surgical retrieval finds usable sperm in about 47% of operations (PMID 31665451) — so the honest answer is “test first, then decide,” not “never.”
Q: Is sterility reversible?
Only some causes. Pituitary-hormonal forms are the clearest win: gonadotropin therapy induced sperm production in 82% of men with prepubertal-onset hypogonadotropic hypogonadism, after a median of 7.5 months of treatment (PMID 40878119).
Radiation-induced ovarian failure, surgically absent testes or an absent uterus are not reversible themselves, though third-party paths may still exist where lawful — and any man using exogenous testosterone should stop, because it suppresses sperm production in the first place.
Q: What is the difference between “subfertility” and “infertility”?
Infertility is the 12-month failure definition; subfertility describes reduced but real spontaneous capacity — these couples conceive, just slower. The glossary keeps them separate because labeling a treatable delay as “sterile” causes people to give up too early.
Q: Does IVF “cure” sterility?
IVF bypasses many infertility mechanisms — tubes, motility, egg pickup — but cannot give a woman eggs she no longer has, or a man sperm his testes no longer make, or a person a uterus they do not have. Where retrieval fails, the IVF pathway continues with donor gametes instead — donor-egg live-birth rates hold near 50–60% per transfer regardless of recipient age: see donor egg IVF.
Q: At 40+, is it infertility or is it sterility?
Mostly the former, declining toward the latter with time. Even at 43–44, a small percentage of natural conceptions using one’s own eggs still occur worldwide, so “sterile” is technically wrong — but own-egg IVF live-birth rates of just 5–10% per transfer at 43+ (against 40–50% under 35; comparison table in donor egg IVF) make the practical difference thin, which is why clinics discuss donor options early.
What to do next
If you have crossed a waiting threshold — or a test has just thrown the word “azoospermia” or “no ovarian reserve” at you — the next step is not a decision about quitting; it is a classification: which of the three states (infertile, subfertile, sterile) actually applies to you, because each has a different next move. A specialist can establish it in one cycle of testing, and the answer changes treatment more than hope does.
Our hospital directory lists fertility clinics by country with services and legal scope, and our contact page connects you with the ProIVF team to compare work-up and treatment paths.
Disclaimer: This article is for educational purposes only and does not constitute medical advice or a diagnosis. Only testing by a qualified fertility professional can establish whether an individual has infertility, subfertility or sterility. If you have been trying to conceive beyond the thresholds above, seek evaluation.
This article was written by the ProIVF Medical Editorial Team and reviewed by the ProIVF Medical Advisory Board. It draws on the peer-reviewed studies linked throughout, the ICMART/WHO international glossary, and reference material from ASRM and ACOG.
Last updated: October 11, 2026
